Medical Diagnostics & Rehabili Springfield, MA - 01104

Medical Diagnostics & Rehabili is categorized under Blood Banks and Centers in Springfield, MA and active since 1999.

Medical Diagnostics & Rehabili was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Banks and Centers business, which does work in the B2C market, and is classified as a Blood Banks and Centers, under code number 621991 by the NAICS.

If you are seeking more information, feel free to contact Mitchell I Clionsky at the company’s single location by writing to 300 Stafford St # 360, Springfield, Massachusetts MA 01104 or by phoning (413) 734-8440. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medical Diagnostics & Rehabili
Contact Person: Mitchell I Clionsky
Address: 300 Stafford St # 360, Springfield, Massachusetts 01104
Phone Number: (413) 734-8440
Annual Revenue (USD): $100.000 to $499.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Blood Banks and Centers
SIC Code: 8099
NAICS Code: 621991
Share This Business:

Medical Diagnostics & Rehabili was started in 1999 to provide professional Blood Banks and Centers under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Mitchell I Clionsky for inquiries that concern Medical Diagnostics & Rehabili by calling the company number (413) 734-8440, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Diagnostics & Rehabili can be found at the coordinates as well as the street address 300 Stafford St # 360 in Springfield, Massachusetts 01104.

For its online presence, you may visit Medical Diagnostics & Rehabili’s website at and engage with its social media outlets through on Twitter and on Facebook.